Dr. Ofer Daphna to Keynote the World Cornea Congress 2025 in D.C.

Dr. Ofer Daphna to Deliver Keynote Lecture at the World Cornea Congress 2025

EyeYon Medical, a leader in innovative corneal implant technologies, is thrilled to announce that Dr. Ofer Daphna, the inventor of the EndoArt artificial endothelial implant, will give a keynote speech at the prestigious World Cornea Congress (WCC) 2025 in Washington, D.C. This significant event is set to take place this weekend, where Dr. Daphna will showcase the remarkable advancements in EndoArt over the past decade.

With a follow-up of nearly six years on 500 patients treated with EndoArt, Dr. Daphna is poised to discuss its revolutionary potential in treating corneal edema. This groundbreaking implant serves as a viable alternative to traditional corneal transplants, addressing an urgent medical need where approximately 70 patients await each available donor cornea.

Dr. Daphna’s presentation will delve deep into the technological evolution of EndoArt, shedding light on its clinical strides and the substantial positive impact it has made on patients globally. As demand for innovative ophthalmic solutions continues to rise, EndoArt stands at the forefront, offering hope to thousands.

The World Cornea Congress is renowned as one of the foremost platforms in the field, attracting leading professionals and fostering collaboration and innovation in corneal care. Dr. Daphna's keynote represents a critical moment in ophthalmology as the field strives for groundbreaking solutions to corneal conditions.

At a time of increasing need for advanced products, EndoArt has become a commercially available solution actively utilized in clinical settings, proving its effectiveness and reliability. During his talk, Dr. Daphna will not only highlight the progressive development of EndoArt, but he will also explore its expanding clinical applications and future potential in reshaping corneal care.

As the world of eye health advancements continues to evolve, EyeYon Medical’s commitment to improving corneal treatments and broaden access to innovative therapies is clearer than ever. Attendees of WCC 2025 can expect a presentation that underscores the importance and viability of novel approaches.

For more details on Dr. Daphna's speech and information about EndoArt, visit EyeYon Medical’s LinkedIn or their official website at www.eye-yon.com.